D-serine adjuvant treatment for Parkinson's disease

Trial Profile

D-serine adjuvant treatment for Parkinson's disease

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jul 2012

At a glance

  • Drugs D-serine (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jul 2012 Actual patient number changed from 5 to 13 as reported by ClinicalTrials.gov.
    • 06 Aug 2008 Patient numbers added as reported by ClinicalTrials.gov.
    • 06 Aug 2008 Additional trial identifier 20030312 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top